Expression of cyclooxygenase-2 and thromboxane synthase in non-neoplastic and neoplastic thyroid lesions

Endocrine Pathology

Volumn 15, Issue 2, 2004, Pages 107-115

  Casey, Mary B ^a,b   Zhang, Shuya ^a   Jin, Long ^a   Kajita, Sabine ^a   Lloyd, Ricardo V ^a  

^a MAYO CLINIC   (United States)

^b Hilton 11 ^*  (United States)

Author keywords

Cyclooxygenase; Immunohistochemistry; Thromboxane synthase; Thyroid carcinoma; Western blot

Indexed keywords

CYCLOOXYGENASE 2; THROMBOXANE SYNTHASE;

ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT NEOPLASTIC DISEASE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUBTOTAL THYROIDECTOMY; THYROID ADENOMA; THYROID CARCINOMA; THYROID DISEASE; THYROID TUMOR; TUMOR GROWTH; WESTERN BLOTTING;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RETROSPECTIVE STUDIES; THROMBOXANE-A SYNTHASE; THYROID NEOPLASMS;

EID: 4444373177     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:15:2:107     Document Type: Article

References (46)

1. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1299:125-140, 1996.
2. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach, S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188, 1994.
3. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57:1276-1280, 1997.
4. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 58:2929-2934, 1998.
5. Hida T, Yatabe Y, Achiwa H, et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58:3761-3764, 1998.
6. Komhoff M, Guan Y, Shappell HW, et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol 157:29-53, 2000.
7. Tucker ON, Dannenberg AJ, Yank EK, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59:987-990, 1999.
8. Karim MM, Hayashi Y, Inoue M, Imai Y, Ito H, Yamamoto M. COX-2 expression in retinoblastoma. Am J Ophthalmol 129:398-401, 2000.
9. Shamma A, Yamamoto H, Doki Y, et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 6:1229-1238, 2000.
10. Yoshimura R, Sano H, Masuda C, et al. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 89:589-596, 2000.
11. Joki T, Heese O, Nikas DC, et al. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60:4926-4931, 2000.
12. Kulkarni S, Rader JS, Zhang F, et al. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 7:429-434, 2001.
13. Denkert C, Kobel M, Berger S, et al. Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61:303-308, 2001.
14. Castilla EA, Prayson RA, Kanner AA, et al. Cyclooxygenase-2 in oligodendroglial neoplasms. Cancer 98:1465-1472, 2003.
15. Bing RJ, Miyataka M, Rich KA, et al. Nitric oxide, prostanoids, cyclooxygenase and angiogenesis in colon and breast cancer. Clin Cancer Res 7:3385-3392, 2001.
16. Cornetta AJ, Russell JP, Cunnane M, Keane WM, Rothstein JL. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis. Laryngoscope 112:238-242, 2002.
17. Specht MC, Tucker ON, Hocerer M, Gonzalez D, Tery L, Fahes TJ. Cyclooxygenase-2 expression in thyroid nodules. J Clin Endocrinol Metab 87:358-363, 2002.
18. Hamberg M, Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71:3400-3404, 1974.
19. Moncada S, Vane JR. Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2. Drug Ther 37-65, 1982.
20. Ogletree ML. Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc 46:133-138, 1987.
21. Zhang L, Chase MB, Shen RF. Molecular cloning and expression of murine thromboxane synthase. Biochem Biophys Res Commun 194:741-748, 1993.
22. Shen RF, Zhang L, Back SJ, Tai HH, Lee KD. The porcine thromboxane synthase-encoding cDNA: sequence, mRNA expression and enzyme production in Sf9 insect cells. Gene 140:261-265, 1994.
23. Tone Y, Miyata A, Hara S, Yukawa S, Tanabe T. Abundant expression of thromboxane synthase in rat macrophages. FEBS Lett 340:241-244, 1994.
24. Honn KV, Busse WD, Sloane BF. Prostacyclin and thromboxanes. Implications of their role in tumor cell metastasis. Biochem Pharmacol 32:1-11, 1983.
25. Honn KV, Meyer J, Neagos G, Henderson T, Westley C, Ratanatharathorn V. Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g6575). Prog Clin Biol Res 89:295-331, 1982.
26. Drago JR, Al-Mondhiry HA. The effect of prostaglandin modulators on prostate tumor growth and metastasis. Anticancer Res 4:391-394, 1984.
27. McDonough W, Tran N, Giese A, Norman SA, Berens ME. Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Exp Neurol 48:449-455, 1998.
28. Giese A, Hagel C, Kim EL, et al. Thromboxane synthase regulates the migratory phenotype of human glioma cells. Neuro-oncol 1:3-13, 1999.
29. Kurzel F, Hagel CH, Zapt S, Meissner H, Westphal M, Giese A. Cyclooxygenase inhibitors and thromboxane synthase inhibitors differentially regulate migration arrest, growth inhibition and apoptosis in human glioma cells. Acta Neurochir (Wien) 144:71-87, 2002.
30. 2 synthase and prostaglandin 12 synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res 62:63-66, 2002.
31. Jin L, Zhang S, Bayliss J, et al. Chromogranin A processing in human pituitary adenomas and carcinomas: analysis and region-specific antibodies. Endocr Pathol 14:37-48, 2003.
32. Riss D, Jin L, Qian X, et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res 63:2251-2255, 2003.
33. Di Paola R, Menzaghi C, de Filippis V, Corda D, di Cerbo A. Cyclooxygenase-dependent thyroid cell proliferation induced by immunoglobulins from patients with Graves' disease. J Clin Endocrinol Metab 82:670-673, 1997.
34. Berg J, Stocher M, Bogner S, Wolfl S, Pichler R, Stekel H. Inducible cyclooxygenase-2 gene expression in the human thyroid cell line Nthy-ori3-1. Inflamm Res 49:139-143, 2000.
35. Jones, MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5:1418-1423, 1999.
36. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-816, 1998.
37. Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59:4574-4577, 1999.
38. Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60:1306-1311, 2000.
39. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 105:1589-1594, 2000.
40. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94:3336-3340, 1997.
41. Kim HS, Youm HR, Lee JS, Min KW, Chung JH, Park CS. Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer. Lung Cancer 42(2):163-170, 2003.
42. Kong G, Kim EK, Kim WS, et al. Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer. J Gastroenterol Hepatol 17(8):914-921, 2002.
43. Raspollini MR, Amunni G, Villanucci A, et al. COX-2 status in relation to tumor microvessel density and VEGFexpression: analysis in ovarian carcinoma patients with low versus high survival rates. Oncol Rep 11(2):309-313, 2004.
44. Leung WK, To KF, Go MY, et al. Cyclo-oxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int J Oncol 23(5):1317-1322, 2003.
45. Xiong B, Sun TJ, Yuan HY, Hu MB, Hu WD, Cheng FL. Cyclooxygenase-2 expression and angiogenesis in colorectal cancer. World J Gastroenterol 9(6):1237-1240, 2003.
46. Kase S, Osaki M, Honjo S, et al. Expression of cyclooxygenase 2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas. Virchows Arch 442(2): 129-135, 2003.